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ABSTRACT 
Leucine, a naturally occurring α-amino acid, has been found as an effective catalyst to effect the one-pot three-component 
condensation reaction between aromatic aldehydes, malononitrile and 5,5-dimethyl-1,3-cyclohexanedione (dimedone). 
Various 2-amino-4-aryl-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile derivatives are conveniently 
prepared by these reactions in excellent yields. High yields, short reaction times, simple work-up, use of green and 
naturally occurring catalyst and solvent are the main merits of the present protocol. 
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1. INTRODUCTION  
        Combined with the growing interest in the production of different industrial and synthetic organic and bioorganic 
products, there has also been great concern on the environmental issue in recent years. In this regard, the research 
workers in synthetic organic chemistry find themselves responsible to comply with the principles of green chemistry [1]. 
Accordingly, development of benign and environmentally friendly approaches employing non-polluting and naturally 
occurring reagents and catalysts such as amino acids and minerals has become an interesting challenge in synthetic 
organic chemistry [2]. 
Among the heterocyclic compounds, pyrans belong to an important class of heterocyclic compounds and constitute the 
largest portion of chemical scaffolds which are part of many natural products [3]. Some derivatives of pyrans including 
chromenes exhibit wide range of biological activities [4], and possess molluscicidal [5], anticancer [6], antitubercular, 
anticoagulant, antiallergic, antibiotic, hypolipidemic, and immunomodulating properties [7]. These compounds are also 
industrially important as cosmetics, pigments and potentially biodegradable agrochemicals [8]. As a result, in recent years, 
much research activities in synthetic organic chemistry have been dedicated to the synthesis of 4H-chromenes due to their 
biological and pharmacological activities. Until now, several methods have been reviewed in the literature for the synthesis 
of 4H-chromenes that employ various reagents and catalysts such as n-Bu4NF [9], magnetic nanocatalysts [10], lipase 
[11], mesoporous silica nanoparticles [12], lithium bromide [13], piperidine [14], magnesium oxide [15], and silica-bonded 
n-propyl-4-aza-1-azoniabicyclo [2.2.2] octane chloride [16]. However, many of these procedures suffer from certain 
drawbacks such as environmentally unpleasant use of huge organic solvents and hazardous reagents, long reaction time, 
low yield, costly preparation of catalysts, and stringent reaction conditions. Hence, development of more benign synthetic 
strategies in this field using non-toxic reagents and catalysts appears as interesting challenge. In compliance with this 
requisition, herein, we are encouraged to explore the hitherto unreported application of leucine amino acid as naturally 
occurring green catalyst to conveniently affect the synthesis of 4H-chromenes in excellent yields and short reaction times. 
2. EXPRIMENTAL 
2.1 General 
All the chemicals used in this work were purchased from Merck chemical company and used without purification. Infrared 
(FT-IR) spectra were recorded on a Shimadzu 435-U-04 FT spectrophotometer from KBr pellets. 
1
H NMR spectra were 
measured for samples in CDCl3 or d6-DMSO using a BRUKER AVANCE DRX-90 instrument at 90 MHz, using Me4Si as 
internal standard. Melting points were measured on a BUCHI 510 apparatus in open capillary tubes. 
2.2 Typical procedure for the synthesis of 4H-chromenes 4 
To a mixture of aromatic aldehyde 1 (1 mmol), malononitrile 2 (0.066 g, 1 mmol), and dimedone (0.14 g, 1 mmol) in 
absolute ethanol (10 mL), was added leucine (0.02 g, 0.15 mmol). The mixture was refluxed for an appropriate time (Table 
2). After completion of the reaction as monitored by TLC analysis, the resulting reaction mixture was cooled to room 
temperature, diluted with distilled water (30 mL) and stirred for few minutes. The precipitated product was collected by 
filtration, washed with water and dried in oven. Recrystallization of the crude products from EtOAc/n-hexane (1:3) provided 
pure products 4. All the products obtained are known compounds which were characterized based on their melting points 
and spectral (FT-IR, 
1
H NMR) data as given below and compared with those reported in the literature (Table 2).  
2.3 Characterization data of the synthesized 4H-chromenes 4a-k 
2-Amino-7,7-dimethyl-5-oxo-4-phenyl-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (4a) 
White solid; m.p. 235–238 ˚C; IR (KBr) (νmax, cm
-1
): 3395, 3324, 3251, 3212, 2961, 2199, 1680, 1660, 1603, 1370, 1249, 
1214, 1159, 1139, 1035, 696; 
1
H NMR (90 MHz, CDCl3): δ = 1.049 (s, 3H, CH3), 1.119 (s, 3H, CH3), 2.23 (s, 2H, CH2), 
2.456 (s, 2H, CH2), 4.411 (s, 1H, CH), 4.451 (s, 2H, NH2), 7.249 (s, 5H, H-Ar) ppm. 
2-Amino-4-(4-chlorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (4b) 
White solid; m.p. 215–217 ˚C; IR (KBr) (νmax, cm
-1
): 3358, 3325, 3358, 3185, 3966, 2192, 1683, 1655, 1605, 1488, 1413, 
1369, 1252, 1215, 1160, 1142, 1091, 1038, 1014, 847, 564, 514; 
1
H NMR (90 MHz, d6-DMSO): δ = 0.943 (s, 3H, CH3), 
1.031 (s, 3H, CH3), 2.156 (s, 2H, CH2), 2.505 (s, 2H, CH2), 4.195 (s, 1H, CH), 7.058-7.305 (s, 6H, H-Ar and NH2) ppm. 
2-Amino-4-(2-chlorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (4c) 
White solid; m.p. 212–215 ˚C; IR (KBr) (νmax, cm
-1
): 3361, 3328, 3256, 3199, 2962, 2198, 1681, 1665, 1602, 1368, 1251, 
1214, 1159, 1142, 1038, 751, 561; 
1
H NMR (90 MHz, CDCl3): δ = 1.078 (s, 6H, CH3), 2.202 (s, 2H, CH2), 2.439 (s, 2H, 
CH2), 4.80 (s, 3H, CH and NH2), 7.173 (s, 4H, H-Ar) ppm. 
2-Amino-4-(3-chlorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (4d) 
White solid; m.p. 220-223 ˚C; IR (KBr) (νmax, cm
-1
): 3473, 3394, 3329, 3198, 2960, 2199, 1682, 1654, 1604, 1370, 1214, 
1037, 750, 562; 
1
H NMR (90 MHz, CDCl3): δ = 1.073 (s, 6H, CH3), 2.213 (s, 2H, CH2), 2.447 (s, 2H, CH2), 4.650 (s, 2H, 
NH2), 4.845 (s, 1H, CH), 7.192 (s, 4H, H-Ar) ppm. 
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2-Amino-4-(4-fluorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (4e) 
White solid; m.p. 190–192 ˚C; IR (KBr) (νmax, cm
-1
): 3364, 3332, 3258, 3187, 2963, 2190, 1738, 1684, 1652, 1603, 1369, 
1215, 1039, 850, 567; 
1
H NMR (90 MHz, d6-DMSO): δ = 0.952 (s, 3H, CH3), 1.032 (s, 3H, CH3), 2.163 (s, 2H, CH2), 2.504 
(s, 2H, CH2), 4.194 (s, 1H, CH), 7.033-7.172 (m, 6H, H-Ar and NH2) ppm. 
2-Amino-4-(3-nitrophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (4f) 
White solid; m.p. 218-220 ˚C; IR (KBr) (νmax, cm
-1
): 3430, 3335, 3251, 3203, 2957, 2204, 2186, 1680, 1661, 1638, 1599, 
1530, 1417, 1374, 1349, 1251, 1210, 1158, 1138, 1038, 826, 733, 690; 
1
HNMR (90 MHz, CDCl3): δ = 1.057 (s, 3H, CH3), 
1.131 (s, 3H, CH3), 2.240 (s, 2H, CH2), 2.501 (s, 2H, CH2), 4.534 (s, 1H, CH), 4.749 (s, 2H, NH2), 7.565 (m, 3H, H-Ar), 
8.043 (s, 1H, H-Ar) ppm. 
2-Amino-4-(2-methoxyphenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile 
(4g) 
White solid: m.p. 202-205 ˚C; IR (KBr) (νmax, cm
-1
): 3564, 3471, 3328, 3184, 2959, 2934, 2880, 2835, 2199, 1686, 1662, 
1600, 1493, 1463, 1368, 1254, 1214, 1162, 1143, 1034, 860, 755; 1H NMR (90 MHz, CDCl3): δ = 1.053 (s, 3H, CH3), 
1.117 (s, 3H, CH3), 2.215 (s, 2H, CH2), 2.441 (s, 2H, CH2), 3.832 (s, 3H, CH3), 4.479 (s, 2H, NH2), 4.710 (s, 1H, CH), 
6.888 (m, 2H, H-Ar), 7.070 (m, 2H, H-Ar) ppm. 
2-Amino-7,7-dimethyl--5-oxo-5,6,7,8-tetrahydro-4-(p-tolyl)-4H-chromene-3-carbonitrile (4h) 
White solid; m.p. 212–215 ˚C; IR (KBr) (νmax, cm
-1
): 3356, 3258, 3187, 3022, 2964, 2926, 2193, 1682, 1655, 1604, 1511, 
1412, 1368, 1322, 1250, 1214, 1160, 1140, 1037, 843, 770, 567; 
1
H NMR (90 MHz, CDCl3): δ = 1.098 (s, 6H, CH3), 2.281 
(s, 5H, CH3 and CH2), 2.455 (s, 2H, CH2), 4.377 (s, 1H, CH), 4.495 (s, 2H, NH2), 7.106 (s, 4H, H-Ar) ppm. 
2-Amino-4-(2,5-dimethoxyphenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile 
(4i) 
White solid; m.p. 183-186 ˚C; IR (KBr) (νmax, cm
-1
): 3394, 3333, 3259, 3215, 2995, 2960, 2835, 2193, 1682, 1660, 1604, 
1500, 1464, 1423, 1373, 1266, 1248, 1212, 1158, 1142, 1048, 797, 730, 561; 
1
H NMR (90 MHz, CDCl3): δ = 1.062 (s, 3H, 
CH3), 1.105 (s, 3H, CH3), 2.216 (s, 2H, CH2), 2.430 (s, 2H, CH2), 3.728 (s, 3H, CH3), 3.796 (s, 3H, CH3), 4.544 (s, 2H, 
NH2), 4.682 (s, 1H, CH), 6.635-6.754 (m, 3H, H-Ar) ppm. 
2-Amino-4-(p-hydroxyphenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (4j) 
White solid; m.p. 207–209 ˚C; IR (KBr) (νmax, cm
-1
): 3362, 3331, 3256, 3193, 2964, 2894, 2193, 1682, 1651, 1605, 1512, 
1448, 1414, 1371, 1252, 1215, 1143, 1039, 846, 633, 561; 
1
H NMR (90 MHz, d6-DMSO): δ = 0.90 (s, 3H, CH3), 0.974 (s, 
3H, CH3), 2.131 (s, 2H, CH2), 2.445 (s, 2H, CH2), 4.007 (s, 1H, CH), 6.630 (s, 2H, NH2), 6.847 (s, 4H, H-Ar), 9.191 (s, 1H, 
OH) ppm. 
2-Amino-4-(p-nitrophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (4k) 
Cream solid; m.p. 182–185 ˚C; IR (KBr) (νmax, cm
-1
): 3482, 3451, 3374, 3333, 3257, 3216, 3074, 2960, 2876, 2196, 1688, 
1671, 1594, 1511, 1471, 1362, 1345, 1218, 1159, 1141, 1039, 1010, 866, 828, 743, 700, 562; 
1
H NMR (90 MHz, d6-
DMSO): δ = 0.967 (s, 3H, CH3), 1.044 (s, 3H, CH3), 2.173 (s, 2H, CH2), 2.534 (s, 2H, CH2), 4.371 (s, 1H, CH), 7.180-7.186 
(m, 4H, H-Ar), 8.127 (s, 2H, NH2) ppm. 
3. RESULTS AND DISCUSSION  
As part of our ongoing interest for developing more convenient and robust approaches for the synthesis of organic 
products including heterocyclic compounds of biological and synthetic importance such as 4H-chromenes [17-19], herein, 
we wish to report the useful application of leucine as highly efficient and green catalyst in one-pot three-component 
condensation of aromatic aldehydes 1a-k with malononitrile 2 and 5,5-dimethyl-1,3-cyclohexanedione (dimedone) 3 
(Scheme 1). The reactions proceed within few minutes under reflux condition in EtOH to afford the respective 4H-
chromenes 4a-k in excellent yields (Table 2). 
 
Scheme 1. Leucine-catalyzed one-pot synthesis of 4H-chromenes 4a-k. 
Initially, we chose the reaction between benzaldehyde, malononitrile and dimedone as the model reaction to establish the 
reaction conditions. The effects of solvent and other reaction conditions on this reaction were investigated using different 
solvents such as THF, EtOH, H2O and CH3CN under various temperatures and catalyst loadings (Table 1). As shown in 
Table 1, the best results in terms of yield (98%) and reaction time (10 min) were obtained when the reaction was 
conducted in absolute ethanol as the solvent of choice under reflux condition in the presence of leucine (15 mol%)  as the 
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catalyst (entry 7). It was observed that further increasing the amount of the catalyst did not have any improving effect on 
the yield of the reaction. In addition, the important role of the catalyst in the reaction was substantiated when the reaction 
was performed in the absence of the catalyst that resulted in a very low yield (15%) of the expected product (entry 11).
  
Table 1. Screening the reaction parameters on the leucine-catalyzed model reaction between benzaldehyde, 
malononitrile and dimedone
a
 
 
Entry Solvent Catalyst (mol %) Temperature (°C) Time (min) Yield (%)
b 
1 EtOH  10 rt 60 40 
2 EtOH 10  50 40 65 
3 H2O 10 50 60 58 
4 CH3CN 10  50 40 30 
5 THF 10  50 40 46 
6 EtOH 10  reflux 20 90 
7 EtOH 15 reflux 10 98 
8 EtOH 20 reflux 10 95 
9 EtOH 30 reflux 20 92 
10 EtOH 50 reflux 20 85 
11 EtOH 0 reflux 60 15 
a 
Conditions: benzaldehyde (1 mmol), dimedone (1 mmol), malononitrile (1 mmol), solvent 
(10 mL). 
b 
Isolated yield. 
To establish the generality of the reaction, we extended the scope of the reaction to a series of aldehydes bearing different 
substituents 1a-k under the aforementioned optimized conditions (leucine (15 mol%)/EtOH/reflux) (Scheme 1). According 
to the experimental results summarized in Table 2, all the reactions proceeded smoothly within short reaction times (10-50 
min) to furnish the corresponding 4H-chromenes 4a-k with excellent yields (88-98%). All the products are known 
compounds which were characterized on the basis of their physical and spectral (FT-IR, 
1
H NMR) data which were in 
accord with those reported in the literature (Table 2). 
Table 2. Leucine-catalyzed synthesis of 4H-chromene-3-carbonitriles 4a-k in EtOH under reflux.
a 
 
M.p. (°C) 
Yield (%)
b 
Time (min) Product  Ar Entry 
Reported
 
Found 
234-235 [8] 235-238 98 10 4a C6H5 1 
215-216 [8] 215-217 98 10 4b 4-ClC6H4 2 
214-215 [20] 212-215 95 20 4c 2-ClC6H4 3 
224-226 [21] 220-223 89 30 4d 3-ClC6H4 4 
191-193 [20] 190-192 90 20 4e 4-FC6H4 5 
213-217 [22] 218-220 98 20 4f 3-NO2C6H4 6 
181-184 [22] 182-185 95 10 4g 4-NO2C6H4 7 
203-205 [11] 202-204 90 50 4h 2-MeOC6H4 8 
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178-180 [21] 180-183 94 30 4i 2,5-(MeO)2C6H3 9 
210-213 [19] 212-215 94 20 4j 4-MeC6H4 10 
206-208 [12] 207-209 88 40 4k 4-HOC6H4 11 
a
 Conditions: aldehyde (1 mmol), dimedone (1 mmol), malononitrile (1 mmol), leucine (0.02 g, 
15 mol%), EtOH (10 mL), reflux. 
b
 Isolated yields. 
A feasible mechanism suggested to explain the formation of 4H-chromenes 4 from the condensation of aldehydes 1 with 
malononitrile and dimedone under the catalytic effect of leucine is depicted in Scheme 2. As illustrated, leucine acts as an 
amino acid to make use of its ambivalent character to provide a 'proton' at acidic site to activate the aldehyde, while it 
accepts a 'proton' from malononitrile at amino site. The resulting malononitrile carbanion undergoes a Knoevenagel-type 
condensation with protonated aldehyde leading to the dehydrative formation of arylidenemalononitrile intermediate ( I). 
Subsequently, the enolate formed from the proronated dimedone undergoes addition to intermediate (I) to form the 
intermediate adduct (II) followed by intramolecular cyclization to furnish the products 4. 
 
Scheme 2. A possible mechanism for the leucine-catalyzed formation of 2-amino-4-aryl-5-oxo-5,6,7,8-tetrahydro-
4H-chromenes 4. 
 
CONCLUSION 
In conclusion, we have explored the application of leucine as an efficient and naturally occurring green catalyst to effect 
the one-pot three-component condensation of aromatic aldehydes with acrylonitrile and dimedone. The reactions 
proceeded smoothly in EtOH under reflux condition to afford the 4H-chromenes in quantitative yields. Simple manipulation 
of the products, improved yields, shorter reaction times, application of leucine as an inexpensive and naturally occurring 
green catalyst, and also use of ethanol as a relatively environmentally benign solvent are the main advantages of the 
present procedure. 
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